About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Psoriasis Clinical Trials | 694 Studies Recruiting

Clinical TrialsPsoriasis

Psoriasis Clinical Trials

Browse 694 clinical trials for psoriasis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 694 trials

CompletedStudy of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis SubjectsThe 13G01 clinical trial is a Phase I/II dose escalation study designed to be conducted in adults with inflammatory arthritis who have persistent moderate or severe swelling in…NCT00126724·Glendale, Arizona and 21 others

Related Searches

psoriatictrials

Data from ClinicalTrials.govTerms

CompletedRAFTLIN-1 Levels in Axial Spondyloarthritis and Psoriatic ArthritisUnlike other rheumatic diseases, acute phase reactants such as C-reactive protein and erythrocyte sedimentation rate are not diagnostic for patients with Spondyloarthropathies…NCT05771389·Istanbul

TerminatedChanges in Body Composition Under Ustekinumab in PsAThere is not much body composition and bone mineral density data available for patients with psoriatic arthritis (rheumatoid arthritis) compared to control subjects.NCT03823924·Lille

CompletedRole of Topical Treatments in the Modulation of Skin Microbiome in Psoriatic SkinChanges in microbiome have been reported recently in psoriasis lesions compared to healthy surround skin.NCT03584360·Nice

CompletedA Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic ArthritisThe main purpose of this study is to evaluate the effectiveness and safety of ixekizumab versus adalimumab in participants with psoriatic arthritis (PsA) who are biologic…NCT03151551·Ciudad Autonoma de Buenos Aire, Buenos Aires and 130 others

WithdrawnDo Nanobubbles Improve Joint Hypoxia?Inflamed joints in patients with rheumatoid arthritis and psoriatic arthritis are characterized by low oxygen levels and inflammation.NCT04844008·Oxford

CompletedIncidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK RegistryThis was a retrospective cohort study to assess the incidence rate of psoriatic arthritis (PsA) among psoriasis (PsO) patients newly initiated on secukinumab or any…NCT06172426·Basel

UnknownSAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory DiseasesA prospective, longitudinal, multicentre, observational cohort follow-up study conducted in France.NCT05598684·Alès and 95 others

TerminatedVTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)The objective of this study is to evaluate if VTX958 is safe and effective in adult participants with active Psoriatic Arthritis.NCT05715125·Phoenix, Arizona and 45 others

TerminatedAMG 827 in Subjects With Psoriatic ArthritisThe study will examine the safety and effectiveness of AMG 827 for the treatment of psoriatic arthritisNCT01516957·Peoria, Arizona and 30 others

CompletedStudy Evaluating Anxiety and Depression in Patients With Psoriatic ArthritisThis is an epidemiological non-interventional study assessing the prevalence of anxiety and/or depression disorders in patients suffering from Psoriatic Arthritis (PsA) in Spain.NCT00884468·Reus, Tarragona

CompletedTNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium_(TIGERS) StudyThis study compare the genomics profiles in synovial biopsies obtained prior to, and 24 weeks after a biologic disease modifying anti-rheumatic drugs (DMARDs)(Adalimumab…NCT04261010·Ghent, East Flanders and 1 other

CompletedA Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic ArthritisThis is a multicenter, Phase 2, double-blind, placebo-controlled study in subjects with moderately to severely active Psoriatic Arthritis (PsA) who have an inadequate response or…NCT03101670·Brussels and 24 others

CompletedVaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19People with inflammatory diseases are often treated with medications that act to suppress the immune-system, increasing the risk of catching infections.NCT05115370·Nottingham, Nottinghamshire

CompletedThe Norwegian Drug Monitoring StudyInfliximab and other TNF-inhibitors have revolutionised the treatment of several immunological inflammatory diseases.NCT03074656·Oslo, Lørenskog and 20 others

Not yet recruitingGLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic ArthritisBackground Psoriatic arthritis (PsA) patients are at increased risk of cardiovascular disease.NCT07251556

CompletedA Study of Ixekizumab in Participants With Active Psoriatic ArthritisThis study will assess the safety and efficacy of ixekizumab (LY2439821) compared to placebo in participants with active psoriatic arthritis.NCT01695239·Birmingham, Alabama and 115 others

CompletedMonitoring of Inflammatory ConditionsPeople with inflammatory diseases treated with immune-suppressing medication are recommended to have regular blood-tests to monitor for potential side-effects of this treatment on…NCT05458531·Nottingham, Nottinghamshire

RecruitingHLA B Leader in Patients With Psoriatic ArthritisPsoriatic arthritis (PsA), a chronic immune-mediated heterogeneous inflammatory disease characterized by musculoskeletal inflammation (arthritis, enthesitis, spondylitis and…NCT07718815·Amiens, Picardie

CompletedDC-STAMP & TRAF3: Regulators of Osteoclastogenesis and Biomarkers in PsABiologics such as anti-Tumor Necrosis Factor or TNF inhibitor (TNFi) for treatment of Psoriatic Arthritis (PsA) has greatly reduced bone damage.NCT02413749·Rochester, New York

PreviousPage 5 of 35Next